Resource Listings

COVID-19 has shaken up the healthcare industry in many ways.  Following a downturn in early 2020, merger and acquisition (M&A) activity is expected to return, to support recovery and stabilize post-pandemic operations. This list summarizes ten key considerations specific to healthcare M&A transactions.

This sample form provides a template for a financial disclosure between the Principal Investigator, each Co-Investigator, and each Sub-Investigator involved in the treatment or evaluation of research subjects in a study. The details of this form should be restructured to your specific situation as a result of legal consultation.

This sample policy provides a brief overlook of all components to consider when drafting a professional services agreement. This sample policy is developed for the perspective of an entity employing or contracting for services of an individual professional or group of professionals. The document is NOT intended as an exhaustive list. The document should be tailored to your unique situation and any specific legal questions through legal consultation.

This checklist provides entities a comprehensive list and tips of components and terms to consider when drafting a vendor contract. This material should be tailored to your specific situation and legal questions through legal consultation.

This sample form provides a template for a voluntary self-disclosure with the Office of Inspector General. Self-disclosure gives providers the opportunity to avoid the costs and disruptions associated with a Government-directed investigation and civil or administrative litigation. This document should be tailored to your specific situation and legal questions through legal consultation.

This sample checklist provides a comprehensive list of components to be considered in an employment contracts audit. The checklist should be adapted to your unique situation and legal questions through legal consultation.

This checklist can be used as a starting point for assessing legal issues in negotiation for software/technology services from a Buyer's standpoint. 

This sample form provides a Research Misconduct Policy that assists research staff members to establish and maintain high standards of ethical practices in research. The form contains policy that describes ongoing obligations of research staff to promote an environment that supports ethical research and process.

This tool is designed to assess existing hospital/physician relationships that could identify potential violations of the federal Stark Law, Anti-Kickback Statute (AKS) or False Claims Act (or similar state laws), which could trigger disclosure and/or repayment obligations.

These ten issues reflect the current focus on compliance within the industry in the US, as well as what we expect going forward in 2020.

These are the top US healthcare predictions for 2020 and beyond.

In this article, learn key features of healthcare compliance programs in the United States.

This sample contract describes an agreement made between two parties to transfer tangible materials to be used for research purposes. The sample contract should be adapted to your unique situation and specific legal questions through legal consultation.

Learn about enforcement action taken by the US Centers for Medicare and Medicaid Services (CMS) in 2022 against hospitals, to enforce CMS's Hospital Price Transparency Rule that took effect on January 1, 2021.

Learn more about the new Special Fraud Alert published by the Office of Inspector General, U.S. Department of Health and Human Services on arrangements with telemedicine companies, setting forth seven characteristics OIG believes could suggest a given arrangement poses a heighted risk of fraud and abuse.

Many California health care providers, including hospitals and physician groups, will soon be required to sign on to California’s first-ever statewide data sharing agreement governing the exchange of health and social services information. Learn more here.

The Center for Medicare and Medicaid Innovation (CMMI) is launching a long awaited new oncology model, the Enhancing Oncology Model (EOM). Learn more about the successor to the Oncology Care Model (OCM), which ended June 30, 2022, here.

The Centers for Medicare and Medicaid Services (CMS) has announced that it “fully expects” to reverse
Medicare Part B rate cuts for separately payable drugs acquired through the 340B Drug Pricing Program,
resulting in an estimated additional $1.96 billion for 340B hospitals. Learn more through this blog post released by Foley & Lardner.

On July 7, 2022, the Centers for Medicare and Medicaid Services (CMS) released its proposed 2023 Medicare Physician Fee Schedule (PFS) rule. Learn more about this rule by checking out this article released by Foley and Lardner.

On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) proposed five new changes to Remote Therapeutic Monitoring (RTM) services under the Medicare program. The changes are part of the proposed 2023 Medicare Physician Fee Schedule rule. To learn more check out this Foley & Lardner article.

Check out this resource developed by Foley & Lardner LLP that focuses on the top seventeen trends for the health & life sciences sector in 2022.

Check out this whitepaper developed by Foley & Lardner LLP to learn more about the top twelve trends in the digital assets space.